Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Exp Clin Endocrinol Diabetes ; 120(5): 303-7, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22421985

RESUMO

This study aimed to evaluate the genotoxicity (DNA damage levels) in lymphocyte samples from pregnant Wistar rats with severe or mild diabetes and in whole blood samples from their newborns. Wistar female rats (1 and 90 days of age) and male rats (approximately 90 days of age) were used. The experiment consisted of 2 experimental groups (n=8 animals/group): 1) rats with severe diabetes, 2) rats with mild diabetes. For mild diabetes induction, the rats received streptozotocin (STZ) subcutaneously (100 mg/kg body weight) at day of birth, and those showing glycemia from 120 to 300 mg/dL in their adult life were included. For induction of severe diabetes, adult rats received 40 mg/kg STZ (intravenous route), and those showing glycemia > 300 mg/dL were included. At day 21 of pregnancy, the rats were anesthetized and euthanized for removal of maternal and fetal blood samples for determination of the oxidative DNA damage by applying Endo III and Fpg using the comet assay. Thus, the rats with mild diabetes and their offspring showed higher Fpg-sensitive sites, reflecting the damage resulting from hyperglycemia. The rats with severe diabetes and their offspring showed higher oxidative DNA damage detected by Fpg and Endo III-sensitive sites, showing general repercussions related to diabetes. The enzymatic treatment for DNA damage evidenced that the maternal repercussions of diabetes are associated with oxidative DNA damage of their newborn, which was not reflected using only the analysis of DNA damage free of the enzymes.


Assuntos
Dano ao DNA , Diabetes Mellitus Experimental/sangue , Estresse Oxidativo/fisiologia , Gravidez em Diabéticas/sangue , Animais , Animais Recém-Nascidos , Glicemia/metabolismo , Ensaio Cometa , Diabetes Mellitus Experimental/genética , Feminino , Masculino , Estresse Oxidativo/genética , Gravidez , Gravidez em Diabéticas/genética , Ratos , Ratos Wistar
2.
Exp Clin Endocrinol Diabetes ; 119(9): 549-53, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21667441

RESUMO

BACKGROUND: Maternal hyperglycemia during early pregnancy is associated with increased risk of abnormalities in the offspring. Malformation rates among the offspring of diabetic mothers are 2-5-fold higher than that of the normal population, and congenital malformations are the major cause of mortality and morbidity in the offspring of diabetic mothers. Metabolic changes, such as hyperglycemia and the metabolites obtained from cigarettes both increase the production of reactive oxygen species (ROS) in the embryo or fetus, causing DNA damage. OBJECTIVE: To evaluate the maternal and fetal genotoxicity, and to assess the incidence of fetal anomaly in diabetic female rats exposed to cigarette smoke at different stages of pregnancy in rats. MATERIAL AND METHOD: Diabetes was induced by streptozotocin administration and cigarette smoke exposure was produced by a mechanical smoking device that generated mainstream smoke that was delivered into a chamber. Female Wistar rats were randomly assigned to: non-diabetic (ND) and diabetic (D) groups exposed to filtered air; a diabetic group exposed to cigarette smoke prior to and during pregnancy (DS) and a diabetic group only exposed to cigarette smoke prior to pregnancy (DSPP). On pregnancy day 21, blood samples were obtained for DNA damage analysis and fetuses were collected for congenital anomaly assessment. Statistical significance was set at p<0.05 for all analysis. RESULTS AND CONCLUSION: Exposure of diabetic rats to tobacco smoke prior to pregnancy increased fetal DNA damage, but failed to induce teratogenicity. Thus, these results reinforce the importance for women to avoid exposure to cigarette smoke long before they become pregnant.


Assuntos
Anormalidades Induzidas por Medicamentos/patologia , Dano ao DNA , Diabetes Mellitus Experimental/fisiopatologia , Feto/efeitos dos fármacos , Exposição Materna , Gravidez em Diabéticas/fisiopatologia , Poluição por Fumaça de Tabaco/efeitos adversos , Anormalidades Induzidas por Medicamentos/sangue , Anormalidades Induzidas por Medicamentos/embriologia , Anormalidades Induzidas por Medicamentos/etiologia , Animais , Câmaras de Exposição Atmosférica , Ensaio Cometa , Diabetes Mellitus Experimental/sangue , Diabetes Mellitus Experimental/induzido quimicamente , Feminino , Desenvolvimento Fetal/efeitos dos fármacos , Feto/patologia , Hiperglicemia/etiologia , Leucócitos/efeitos dos fármacos , Leucócitos/patologia , Gravidez , Gravidez em Diabéticas/sangue , Distribuição Aleatória , Ratos , Ratos Wistar , Fumar/efeitos adversos , Fumar/sangue , Fumar/patologia , Estreptozocina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA